ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2023

Apr 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2023-03-31

Reporting Person: Donhauser Peter D.O. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-31	Stock Option (Right to Buy)	$8.57	A	50000	Acquired	2033-03-31	Common Stock (50000)	Direct

Footnotes

F1: Options vest in equal instalments over three years from the grant date